other
previous
identifi
develop
seri
noncoval
sarsplpro
inhibitor
use
highthroughput
screen
ht
structurebas
drug
design
classifi
two
distinct
four
inhibitor
structur
two
scaffold
shown
figur
repres
scaffold
repres
scaffold
inhibitor
exhibit
excel
inhibitori
activ
valu
sarsplpro
sar
antivir
activ
four
sarsplpro
lead
inhibitor
test
mersplpro
determin
whether
two
plpro
enzym
behav
similarli
surprisingli
none
show
inhibitori
activ
mersplpro
result
led
us
analyz
determin
interact
sarsplpro
inhibitor
seven
sarsplpro
crystal
structur
avail
date
four
complex
inhibitor
two
case
mersplpro
one
apo
two
substratebound
complex
recent
also
determin
xray
crystal
structur
unbound
mersplpro
pdb
code
support
inform
tabl
addit
previous
releas
apo
structur
lower
resolut
pdb
code
sarsplpro
mersplpro
contain
two
block
loop
name
could
structur
import
two
correspond
loop
human
ubiquitinspecif
proteas
proven
crucial
block
access
activ
inde
two
sarsplpro
complex
crystal
structur
lead
inhibitor
scaffold
reveal
inhibitor
bind
catalyt
site
plpro
enzym
loop
block
entranc
activ
site
appear
prevent
substrat
access
catalyt
site
inhibit
plpro
enzym
activ
amid
group
inhibitor
form
two
hydrogen
bond
figur
amid
group
inhibitor
also
form
hydrogen
bond
loop
figur
aromat
ring
form
hydrophob
interact
naphthyl
ring
therefor
residu
form
common
key
interact
scaffold
lead
inhibitor
sarscov
plpro
howev
neither
residu
exist
mersplpro
figur
mersplpro
exist
place
sarsplpro
elimin
potenti
hydrogen
bond
inhibitor
addit
second
key
interact
also
imposs
mersplpro
aromat
ring
appar
due
lack
two
key
residu
none
sarsplpro
lead
inhibitor
inhibitori
efficaci
mersplpro
order
analyz
interact
sarsplpro
inhibitor
align
four
avail
complex
one
sarsplpro
complex
ubiquitin
aldehyd
substrat
one
mersplpro
complex
ubiquitin
substrat
apo
structur
sarsplpro
mersplpro
figur
addit
residu
involv
inhibitor
bind
sarsplpro
correspond
residu
mersplpro
compar
three
bat
coronavirus
similar
merscov
bat
coronavirus
residu
compar
includ
activ
site
catalyt
triad
loop
residu
figur
eight
structur
align
well
except
sever
distinct
locat
includ
zincbind
motif
region
zinc
atom
shift
similar
distanc
locat
five
sarsplpro
complex
structur
compar
apo
structur
note
red
arrow
point
right
bottom
insert
figur
equival
zinc
atom
mersplpro
locat
differ
posit
shift
differ
direct
sarsplpro
dark
brown
arrow
figur
residu
involv
sarsplpro
inhibitor
bind
shown
figur
along
inhibitor
order
illustr
orient
inhibitor
inhibitorinteract
sarsplpro
residu
flexibl
loop
figur
show
bind
locat
inhibitor
ubiquitin
substrat
flexibl
loop
exactli
orient
sarsplpro
flexibl
loop
block
entranc
tunnel
activ
site
unbound
becom
wellord
upon
bind
either
inhibitor
substrat
figur
conform
mersplpro
flexibl
loop
posit
much
activ
site
sarsplpro
unbound
upon
substrat
bind
mersplpro
loop
move
orient
similar
substrat
bound
sarsplpro
loop
note
red
dark
brown
arrow
figur
loop
appear
play
regulatori
role
deubiquitin
mainli
seem
serv
role
sarsplpro
question
whether
loop
mersplpro
play
regulatori
role
deubiquitin
activ
remain
answer
prescreen
assay
optim
prior
larg
scale
ht
crucial
achiev
high
qualiti
outcom
essenti
factor
consider
includ
enzym
substrat
concentr
addit
deterg
reduc
agent
dmso
toler
enzym
stabil
import
factor
substrat
concentr
recommend
use
substrat
concentr
near
slightli
lower
micha
constant
km
valu
order
select
competit
noncompetit
km
determin
ubiquitinderiv
peptid
substrat
rlrggamc
sarsplpro
mersplpro
enzym
side
side
comparison
substrat
km
valu
mersplpro
larger
mersplpro
sarscov
respect
support
inform
tabl
therefor
higher
substrat
concentr
use
mersplpro
sarsplpro
ht
screen
kcat
turnov
number
valu
sarscov
larger
mersplpro
made
catalyt
effici
kcatkm
sarsplpro
substrat
higher
mersplpro
accordingli
higher
mersplpro
enzym
concentr
necessari
yield
enzym
activ
signal
similar
sarsplpro
dmso
toler
reduc
agent
effect
two
addit
bsa
triton
effect
enzym
stabil
rt
determin
addit
optim
substrat
enzym
concentr
ht
search
mersplpro
inhibitor
ht
perform
life
chemic
antimicrobialantivir
focus
librari
sarsplpro
mersplpro
overal
screen
hit
valid
process
describ
figur
primari
ht
screen
sarsplpro
perform
duplic
gener
averag
mersplpro
primari
screen
done
singl
pass
ht
hit
inhibit
compound
concentr
cherri
pick
reanalyz
continu
kinet
assay
filter
fals
posit
enzym
omiss
assay
exactli
assay
condit
without
plpro
enzym
perform
remov
fluoresc
signal
interf
compound
confirm
hit
repurchas
inhibitori
activ
valu
determin
full
inhibit
curv
compound
four
compound
figur
three
compound
figur
exhibit
inhibitori
activ
valu
sarsplpro
mersplpro
respect
surfac
plasmon
reson
spr
use
secondari
orthogon
bind
assay
elimin
fals
posit
primari
hit
sinc
primari
screen
done
fluorescencebas
enzymat
assay
bind
affin
hit
compound
determin
measur
dissoci
equilibrium
constant
kd
use
spr
kd
valu
six
hit
compound
compar
figur
compound
four
sarsplpro
hit
bind
enzym
indic
fals
posit
remain
three
confirm
binder
kd
valu
bind
affin
valid
hit
vari
correspond
valu
vari
kd
valu
respect
similar
kd
valu
approxim
greater
valu
three
mersplpro
hit
show
specif
bind
enzym
bind
affin
fals
posit
compound
bind
mersplpro
wherea
compound
bound
nonspecif
three
distinct
bind
pattern
determin
spr
specif
bind
nonspecif
interact
shown
support
inform
figur
interestingli
compound
show
similar
strength
inhibitori
activ
bind
affin
sarsplpro
mersplpro
enzym
two
type
noncoval
small
molecul
inhibitor
scaffold
sarsplpro
previous
discov
research
group
mechan
inhibit
studi
reveal
compound
mixedtyp
inhibitor
valu
greater
indic
bind
alloster
site
catalyt
site
behav
competit
note
lead
inhibitor
bind
flexibl
region
induc
conform
chang
block
substrat
access
catalyt
site
mersplpro
inhibitor
publish
date
identifi
one
compound
inhibit
sarsplpro
mersplpro
mode
inhibit
studi
compound
done
seri
increas
substrat
concentr
enzymecompound
complex
figur
b
kinet
data
fit
four
differ
enzym
inhibit
model
competit
noncompetit
uncompetit
mixedtyp
use
sigmaplot
enzym
kinet
modul
best
fit
equat
select
base
akaik
inform
criterioncorrect
aicc
equat
lowest
aicc
valu
correspond
best
fit
minimum
two
aicc
unit
differ
next
lowest
requir
consid
statist
signific
interestingli
compound
exhibit
mixedtyp
inhibit
sarsplpro
competit
inhibit
mersplpro
substrat
second
best
fit
equat
compound
sarsplpro
noncompetit
inhibit
aicc
valu
lower
best
fit
mixedtyp
inhibit
also
aicc
valu
lower
competit
inhibit
clearli
indic
compound
alloster
inhibitor
sarsplpro
mersplpro
aicc
valu
competit
inhibit
unit
lower
next
lowest
noncompetit
inhibit
larg
aicc
valu
differ
next
best
fit
equat
sar
mersplpro
clear
compound
act
alloster
inhibitor
sarsplpro
act
competit
inhibitor
mersplpro
therefor
compound
inhibit
two
plpro
enzym
via
two
differ
inhibitori
mechan
even
though
inhibitori
activ
similar
valu
sarsplpro
mersplpro
ki
valu
compound
sarsplpro
mersplpro
respect
figur
compound
appear
interact
mersplpro
bind
catalyt
site
sinc
competit
inhibitor
respect
substrat
howev
uncertain
might
bind
sarsplpro
sinc
alloster
inhibitor
first
hypothesi
may
bind
loop
two
sarsplpro
lead
inhibitor
bound
thu
evalu
inhibit
presenc
four
sarsplpro
lead
inhibitor
order
see
addit
effect
figur
bind
locat
inhibitori
activ
valu
would
improv
addit
compound
valu
enhanc
compound
bind
elsewher
inhibitori
activ
four
lead
inhibitor
alon
vari
valu
enhanc
almost
presenc
concentr
slightli
lower
valu
led
us
conclud
bind
alloster
site
sarsplpro
loop
addit
enzymat
mode
inhibit
analysi
competit
spr
studi
compound
sarsplpro
mersplpro
perform
presenc
absenc
substrat
bind
affin
compound
sarsplpro
regardless
substrat
presenc
wherea
compound
mersplpro
weaker
presenc
substrat
alon
result
indic
substrat
compet
bind
site
mersplpro
figur
therefor
enzymat
mechan
inhibit
spr
studi
support
compound
alloster
inhibitor
sarsplpro
competit
inhibitor
mersplpro
order
clarifi
cocrystal
sarsplpro
mersplpro
compound
current
process
concern
potenti
nonspecif
rais
due
fact
newli
identifi
dual
inhibitor
small
fragmentlik
compound
also
exhibit
inhibitori
activ
sarscov
valu
xray
crystallographi
mode
inhibit
studi
show
bind
dimer
interfac
sarscov
inhibit
enzym
activ
break
dimer
sinc
sarscov
function
dimer
unpublish
data
therefor
compound
act
alloster
inhibitor
sarscov
proteas
plpro
wherea
act
competit
inhibitor
mersplpro
investig
specif
lead
inhibitor
control
two
human
cystein
proteas
also
call
human
ubiquitin
ctermin
hydrolas
two
unrel
enzym
hepat
c
viru
serin
proteas
bacillu
anthraci
dihydroorotas
one
human
homologu
close
relat
plpro
make
excel
control
test
select
newli
identifi
inhibitor
structur
align
two
human
homologu
reveal
catalyt
triad
similar
figur
compound
select
sarsplpro
mersplpro
proteas
two
human
cystein
proteas
unrel
enzym
figur
cysteineserin
proteas
mechan
involv
tetrahedr
intermedi
format
follow
nucleophil
attack
cysteineserin
side
chain
gener
oxyanion
close
catalyt
site
interact
neg
charg
tetrahedr
intermedi
stabil
ratia
et
al
demonstr
sarsplpro
locat
catalyt
cystein
play
vital
role
form
hydrogen
bond
hbond
intermedi
hbond
donor
activ
site
show
sarsplpro
mutant
complet
lost
catalyt
howev
mersplpro
activ
site
equival
posit
occupi
capabl
hbond
donor
figur
lei
et
al
recent
demonstr
mutat
result
catalyt
activ
enhanc
indic
mersplpro
oxyanion
hole
may
complet
comparison
sarsplpro
interestingli
leucin
residu
posit
highli
conserv
three
bat
coronavirus
belong
lineag
group
c
merscov
figur
hand
two
human
coronaviru
plpro
enzym
residu
q
hbond
donor
similar
sarsplpro
therefor
anoth
residu
must
play
intermediatestabil
function
mersplpro
asparagin
sarsplpro
highli
conserv
among
variou
coronaviru
plpro
enzym
ratia
et
al
suggest
residu
could
anoth
residu
contribut
oxyanion
hole
stabil
addit
structur
align
activ
site
note
mersplpro
overlap
sarsplpro
suggest
locat
catalyt
cystein
might
residu
play
critic
role
mersplpro
hypothes
two
potenti
mechan
first
side
chain
amin
group
could
form
hbond
intermedi
oxyanion
hbond
donor
figur
altern
carbonyl
group
could
bind
water
molecul
follow
water
form
anoth
hbond
neg
charg
intermedi
figur
posit
two
scenario
could
differ
gener
two
mersplpro
mutant
investig
two
hypothes
enzym
activ
mutant
complet
abolish
mutant
exhibit
wildtyp
mersplpro
activ
figur
indic
residu
inde
crucial
stabil
intermedi
enzym
perform
catalyt
function
stabil
intermedi
via
second
hypothesi
side
chain
could
still
form
hbond
water
molecul
carbonyl
group
aspart
acid
rescu
mersplpro
enzym
activ
howev
mutant
also
show
low
enzym
activ
compar
wildtyp
suggest
second
hypothesi
like
main
stabil
mechan
result
suggest
critic
residu
intermedi
stabil
like
hbond
format
side
chain
amin
group
addit
contain
crucial
residu
stabil
oxyanion
small
loop
residu
next
activ
site
sarsplpro
import
catalyt
activ
via
control
activ
site
access
hydrogen
bond
loop
restrain
loop
conform
prevent
move
block
activ
site
two
residu
mersplpro
conserv
mersplpro
play
role
sarsplpro
figur
sarscov
merscov
caus
contagi
highli
virul
infecti
diseas
human
threaten
public
coronavirus
appar
origin
anim
reservoir
bat
camel
surprisingli
rapidli
evolv
humantohuman
transmiss
although
limit
case
report
sarscov
contain
public
health
measur
sinc
merscov
spread
differ
countri
far
number
infect
continu
rise
current
specif
treatment
vaccin
avail
studi
determin
none
test
sarsplpro
lead
inhibitor
effect
mersplpro
thorough
structur
comparison
two
plpro
enzym
use
avail
structur
reveal
crucial
structur
differ
provid
insight
develop
inhibitor
plpro
overal
mersplpro
structur
similar
sarsplpro
includ
ntermin
ubldomain
howev
flexibl
loop
mersplpro
differ
significantli
sarsplpro
rais
possibl
differ
role
inhibitor
bind
may
explain
observ
test
sarsplpro
lead
inhibitor
ineffect
mersplpro
surpris
discov
sarsplpro
deubiquitin
shown
mersplpro
also
exhibit
determin
catalyt
activ
mersplpro
direct
comparison
sarsplpro
catalyt
effici
kcatkm
sarsplpro
higher
mersplpro
although
deubiquitin
activ
mersplpro
lower
sarsplpro
still
much
activ
two
close
relat
human
homologu
plpro
herpesassoci
ubiquitinspecif
proteas
hausp
ubiquitinspecif
proteas
exhibit
catalyt
effici
perform
ht
compound
plpro
enzym
identifi
dual
noncoval
inhibitor
activ
plpro
enzym
interestingli
inhibitor
determin
competit
inhibitor
mersplpro
wherea
alloster
inhibitor
sarsplpro
result
suggest
inhibitor
recognit
specif
mersplpro
may
differ
sarsplpro
even
though
overal
structur
whole
protein
catalyt
site
similar
probabl
contribut
factor
inhibitor
select
two
plpro
enzym
could
attribut
structur
differ
loop
life
chemic
librari
screen
two
plpro
cystein
proteas
sarscov
merscov
assay
sarsplpro
done
duplic
mersplpro
done
singl
pass
black
plate
matrix
technolog
sarsplpro
enzym
nm
final
concentr
prepar
assay
buffer
mm
hepe
ph
triton
vv
mg
bsa
mm
gsh
mersplpro
enzym
nm
final
concentr
prepar
assay
buffer
mm
dtt
place
mm
gsh
total
enzym
solut
dispens
well
nl
mm
compound
final
concentr
ad
incub
min
enzym
reaction
initi
substrat
zargleuargglyglyamc
bachem
bioscienc
sar
mersplpro
respect
dissolv
assay
buffer
incub
min
follow
ad
sd
wv
stop
solut
fluoresc
intens
monitor
nm
excit
nm
emiss
compound
solut
seri
increas
concentr
dilut
appli
four
channel
flow
rate
sensorgram
analyz
use
biacor
evalu
softwar
respons
unit
measur
equilibr
phase
concentr
plpro
enzym
immobil
sensor
chip
use
standard
aminecoupl
run
buffer
hbsp
mm
hepe
mm
nacl
surfact
ph
use
biacor
instrument
mersplpro
enzym
immobil
flow
channel
immobil
level
flow
channel
ru
ru
respect
sarsplpro
immobil
flow
channel
immobil
level
ru
compar
mersplpro
data
referenc
blank
enthanolamin
ru
valu
sigmaplot
use
fit
data
singl
rectangular
hyperbol
curv
determin
kd
valu
hyperbol
kd
x
use
plot
respons
unit
correspond
concentr
respons
ymax
maximum
respons
x
compound
concentr
enzym
activ
mersplpro
sarsplpro
monitor
way
primari
screen
vari
concentr
inhibitor
substrat
concentr
compound
vari
least
valu
compound
data
fit
four
equat
shown
si
materi
method
use
sigmaplot
enzym
kinet
modul
order
determin
best
fit
inhibit
mechan
kinet
paramet
compound
test
select
two
human
ubiquitin
ctermin
hydrolas
two
unrel
enzym
hepat
c
viru
serin
proteas
b
anthraci
dihydroorotas
test
top
hit
compound
ht
lead
sarsplpro
inhibitor
use
fluorometr
assay
fluorogen
substrat
use
studi
ubiquitinamc
boston
biochem
assay
perform
black
plate
corn
total
volum
assay
buffer
contain
mm
hepe
ph
mm
dtt
mg
bsa
triton
vv
triplic
seri
compound
concentr
final
concentr
serial
dilut
dmso
prepar
plate
compound
solut
prepar
assay
buffer
prior
assay
total
enzym
solut
distribut
well
vari
concentr
compound
ad
incub
min
enzym
reaction
initi
ad
substrat
final
concentr
fluoresc
intens
continu
monitor
excitationemiss
wavelength
nm
min
data
collect
lscat
end
station
advanc
photon
sourc
argonn
nation
laboratori
use
wavelength
crystal
k
dri
liquid
nitrogen
stream
data
record
mar
ccd
mm
detector
oscil
angl
use
total
frame
data
process
scale
crystal
space
group
belong
contain
one
monom
asymmetr
unit
matthew
coeffici
vm
calcul
solvent
content
estim
molecular
replac
carri
use
packag
sarsplpro
crystal
structur
use
search
model
zinc
bind
domain
initi
model
truncat
manual
rebuilt
structur
refin
conduct
use
